Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results

PURPOSE: The purpose of this study was to evaluate the long-term safety, anatomical, and visual outcomes following intravitreal bevacizumab (Avastin; Genentech) on macular edema (ME) secondary to branch retinal vein occlusion (BRVO). METHODS: A prospective, interventional case series study was condu...

Descripción completa

Detalles Bibliográficos
Autores principales: Thapa, Raba, Maharjan, Nhukesh, Paudyal, Govinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413343/
https://www.ncbi.nlm.nih.gov/pubmed/22888203
http://dx.doi.org/10.2147/OPTH.S30555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413343/
https://www.ncbi.nlm.nih.gov/pubmed/22888203
http://dx.doi.org/10.2147/OPTH.S30555

Ejemplares similares